The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis

J Hirsh, JE Dalen, G Guyatt - Chest, 2001 - journal.chestnet.org
Thrombosis, an important complication of atherosclerosis and of various medical and
surgical conditions, can be prevented or treated effectively by a variety of pharmacologic …

The seventh ACCP conference on antithrombotic and thrombolytic therapy: evidence-based guidelines

J Hirsh, G Guyatt, GW Albers, HJ Schünemann - Chest, 2004 - Elsevier
Since the Sixth American College of Chest Physicians Consensus Conference on
Antithrombotic Therapy, the results of clinical trials have provided important new information …

Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …

GH Guyatt, EA Akl, M Crowther, HJ Schünemann… - Chest, 2012 - Elsevier
The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of
Chest Physicians Evidence-Based Clinical Practice Guidelines differs substantially from the …

[图书][B] Guidelines for antithrombotic therapy

J Hirsh - 2004 - books.google.com
Thrombosis can be prevented and treated effectively by a variety of pharmacologic agents.
This monograph provides a summary of the 2003 American College of Chest Surgeons …

Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines

GH Guyatt, EA Akl, M Crowther, DD Gutterman… - Chest, 2012 - journal.chestnet.org
CHEST Skip to Main Content Advertisement CHEST home Submit Log in Register Log in
Submit Log in Subscribe Claim Skip menu Articles Cover Image - CHEST, Volume 164, Issue 6 …

New antithrombotic drugs: antithrombotic therapy and prevention of thrombosis: American college of chest physicians evidence-based clinical practice guidelines

JI Weitz, JW Eikelboom, MM Samama - Chest, 2012 - Elsevier
This article focuses on new antithrombotic drugs that are in or are entering phase 3 clinical
testing. Development of these new agents was prompted by the limitations of existing …

Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis: American …

GH Guyatt, SL Norris, S Schulman, J Hirsh… - Chest, 2012 - Elsevier
Background To develop the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:
ACCP Evidence-Based Clinical Practice Guidelines (AT9), the American College of Chest …

Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence-based clinical practice guidelines

J Hirsh, G Guyatt, GW Albers, R Harrington… - Chest, 2008 - Elsevier
Since publication of the seventh American College of Chest Physicians (ACCP) supplement
on antithrombotic and thrombolytic therapy, the results of clinical trials have provided …

International consensus recommendations: summary statement and additional suggested guidelines

RL Bick, SK Haas - Medical Clinics of North America, 1998 - Elsevier
The primary purpose of a consensus conference is to provide optimal guidance to the
clinician or practitioner in the setting of clinical practice. If the practice guidelines generated …

New antithrombotic drugs: American College of Chest Physicians evidence-based clinical practice guidelines

JI Weitz, J Hirsh, MM Samama - Chest, 2008 - Elsevier
This chapter focuses on new antithrombotic drugs that are in phase II or III clinical testing.
Development of these new agents was prompted by limitations of existing antiplatelet …